CIK 0001484612 · Accelerated filer<br>Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 200514392
- Phone
- 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $46,587
- in 3 filings
Net +$823,674. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Ahmed Nabeel Chief Financial Officer | Grant or award | +13,256 | 293,157 | ||
| 2025-01-13 | Trigg Leslie Chair and CEO | Sale | −33,227 | $0.81 | $27K | 861,397 |
| 2025-01-13 | Nash Marc SVP Operations and R&D | Sale | −15,011 | $0.81 | $12K | 222,291 |
| 2025-01-13 | Brottem John L. General Counsel | Sale | −20,492 | $0.81 | $17K | 205,028 |
| 2025-01-13 | Ahmed Nabeel Chief Financial Officer | Sale | −29,031 | $0.81 | $24K | 279,901 |
| 2025-01-07 | Trigg Leslie Chair and CEO | Sale | −10,227 | $1.29 | $13K | 894,624 |
| 2025-01-07 | Nash Marc SVP Operations and R&D | Sale | −720 | $1.29 | $929 | 237,302 |
| 2025-01-07 | Brottem John L. General Counsel | Sale | −1,572 | $1.29 | $2K | 225,520 |
| 2025-01-07 | Ahmed Nabeel Chief Financial Officer | Sale | −1,835 | $1.29 | $2K | 308,932 |
| 2024-11-15 | Trigg Leslie Chair and CEO | Sale | −5,645 | $0.80 | $5K | 904,851 |
| 2024-11-15 | Nash Marc SVP Operations and R&D | Sale | −1,375 | $0.80 | $1K | 238,022 |
| 2024-11-15 | Brottem John L. General Counsel | Sale | −3,203 | $0.80 | $3K | 227,092 |
| 2024-11-15 | Ahmed Nabeel Chief Financial Officer | Sale | −4,221 | $0.80 | $3K | 310,767 |
| 2024-08-15 | Trigg Leslie Chair and CEO | Sale | −5,308 | $0.84 | $4K | 910,496 |
| 2024-08-15 | Nash Marc SVP Operations and R&D | Sale | −1,293 | $0.84 | $1K | 239,397 |
| 2024-08-15 | Brottem John L. General Counsel | Sale | −3,011 | $0.84 | $3K | 230,295 |
| 2024-08-15 | Ahmed Nabeel Chief Financial Officer | Sale | −3,971 | $0.84 | $3K | 314,988 |
| 2024-07-24 | Nash Marc SVP Operations and R&D | Sale | −723 | $4.02 | $3K | 240,690 |
| 2024-06-12 | Brottem John L. General Counsel | Sale | −10,569 | $4.78 | $51K | 233,306 |
| 2024-06-03 | GROSSMAN D KEITH Director | Option exercise 10b5-1 | +31,186 | $1.11 | $35K | 74,035 |
Page 6 of 8 · 141 trades